CLINICAL TRIALS PROFILE FOR CLOCORTOLONE PIVALATE
✉ Email this page to a colleague
All Clinical Trials for clocortolone pivalate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01714544 ↗ | Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis | Completed | Promius Pharma, LLC | Phase 4 | 2012-10-01 | The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days. |
NCT04358770 ↗ | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Completed | WAYCro | Phase 1 | 2018-03-02 | To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults |
NCT04358770 ↗ | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Completed | Taro Pharmaceuticals USA | Phase 1 | 2018-03-02 | To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for clocortolone pivalate
Condition Name
Clinical Trial Locations for clocortolone pivalate
Trials by Country
Clinical Trial Progress for clocortolone pivalate
Clinical Trial Phase
Clinical Trial Sponsors for clocortolone pivalate
Sponsor Name